A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
about
Cancer immunotherapy: the beginning of the end of cancer?NRP1 function and targeting in neurovascular development and eye diseaseAn integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformationNeuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study.Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.How can we manage resistance to antiangiogenic drugs?Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.Computational systems biology approaches to anti-angiogenic cancer therapeutics.MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.Current drug design to target the Semaphorin/Neuropilin/Plexin complexes.Nordihydroguaiaretic acid impairs prostate cancer cell migration and tumor metastasis by suppressing neuropilin 1.Neuropilin-1 as Therapeutic Target for Malignant Melanoma.Glomerular Mesangial Cell Recruitment and Function Requires the Co-Receptor Neuropilin-1.VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach.Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype.Multifaceted Role of Neuropilins in the Immune System: Potential Targets for ImmunotherapyNew Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer
P2860
Q26752277-17C754D0-0EC8-4171-973A-81E4F713CA29Q26765952-051798B1-0D58-4235-A37A-71B67BE7D1DAQ30581260-C9A8FB5B-704E-4876-B58A-7810D5B80E42Q33789563-C849C612-3AED-47BA-8EDB-6BE955E81773Q33835918-FD40174F-57F7-4706-88ED-B144C6CC7C50Q34702964-64BD25D3-27BF-4CC4-BD22-861AEECAC949Q34774917-33E1FD88-C733-4207-AB9A-4442447BAA00Q35108084-6417B13F-9D21-4BDF-9C8B-6BE07BBFEB50Q35744993-A4C6CD16-1F22-45B9-A81A-E3A54E8549DBQ37124065-5E4FA482-F7B4-4BC8-B7B3-2DB7AD6190ECQ37509064-215CA063-CB3A-4F7E-B188-A31CF488CACCQ37699218-11A273D1-6553-46AE-8D03-04F0D324B366Q38532037-F1DB2AF5-07DE-4D59-B82B-766844F5E189Q38611222-A3273525-A55D-4DA8-ACAE-9EF4D34A638BQ38826861-FE2492CB-6577-47E9-BFC6-AA5F06429982Q38945311-4AF95DC0-F845-4745-8816-3938D7260620Q42654195-EA599511-F200-42CC-8AF6-DBE74E39B9E2Q47221234-FC5ACDCC-2492-4E36-9DF3-13557653C777Q54979733-CA1B24B8-7D9A-44D4-BED0-318477713096Q58738114-D9A184D3-5259-4EEF-A096-B6B3328BE051
P2860
A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 monoclonal antibody, in combination with bevacizumab and paclitaxel in patients with advanced solid tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@ast
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@en
type
label
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@ast
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@en
prefLabel
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@ast
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@en
P2093
P2860
P1476
A Phase Ib study evaluating MN ...... ts with advanced solid tumors.
@en
P2093
Amita Patnaik
Colin D Weekes
Hong Xiang
Joseph C Beyer
Kyriakos P Papadopoulos
L Mason Shih
Muralidhar Beeram
Patricia M LoRusso
P2860
P2888
P304
P356
10.1007/S00280-014-2426-8
P577
2014-03-17T00:00:00Z
P6179
1031221075